alexa Ebola Outbreak in West Africa | Open Access Journals
ISSN: 1948-5964
Journal of Antivirals & Antiretrovirals
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Ebola Outbreak in West Africa

Lul Raka*

National Institute of Public Health of Kosova and Medical School, University of Prishtina, Prishtina, Kosova

*Corresponding Author:
Lul raka
National Institute of Public Health of Kosova and Medical School
University of Prishtina, Prishtina, Kosova
Tel: +37744368289
E-mail: [email protected]

Received Date: January 12, 2015; Accepted Date: January 15, 2015; Published Date: January 22, 2015

Citation: Raka L (2015) Ebola Outbreak in West Africa. J Antivir Antiretrovir 7:XLV-XLV. doi: 10.4172/jaa.1000e122

Copyright: © 2015 Raka L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Antivirals & Antiretrovirals

Ebola Viral Disease (EVD) is a severe and life-threatening disease with fatality rate of up to 90%. The origin of the virus is unknown, but fruit bats of Pteripodidae family are considered to be reservoirs of the virus. EVD spreads through direct contact with body fluids (stool, vomit, blood, urine, saliva, semen and breast milk) of a sick person with EVD [1]. The disease can also be transmitted through direct contact with the deceased person’s body during funeral or burial preparation or ceremonies. Ebola can be contracted also by contact with surfaces or equipment contaminated by body fluids of an infected person [2]. The incubation period for Ebola is 2 to 21 days. Symptoms and signs of disease are fever, intense weakness, muscle pain, headache and sore throat followed by vomiting, diarrhea and bleeding. Early diagnosis is done by detecting virus in blood with serological techniques and molecular tests [3]. There is no cure for the disease and treatment is only supportive, through rehydration. Potential vaccines are undergoing human safety testing, but are not yet in clinical use.

Current epidemic of Ebola in West Africa is the 25th outbreak since 1976. The World Health Organization (WHO) declared epidemic as “public health emergency of international concern” [4]. This Ebola epidemic is different from all others because it is the first one to appear in West Africa, is the largest and longest and involves urban centers including capital cities [5]. Until the end of 2014 there has been 20,000 reported cases of EVD, causing around 7900 deaths. The most affected countries are Liberia, Sierra Leone and Guinea. This outbreak was also characterized with aggressive transmission among Health Care Workers (HCW). A total of 650 HCW were infected causing 359 deaths [6]. Countries in this part of the world have gone through decades of civil war leading to destruction of their resources and health care systems, which are characterized with low numbers of health care workers and insufficient capacities in surveillance and information. Many hospitals were closed because of fears of the health care workers. Guidelines of international organizations (WHO, CDC, MSF) very often remained solely on paper. Dissemination of disease in capital cities made contact investigation a great challenge. Other challenges in the field were waste management in health care facilities and coordination between national and international partners. Response from the international community had a great impact in response to the epidemic. Community care centers were institutionalized in some countries looking for alternative ways to decrease the number of cases [7].

The primary interventions to prevent EVD are: early diagnosis, isolation of patients, contact tracing and monitoring, safe burials, infection prevention and control and decreased social mobilization. The implementation of all these components was challenged in the field [8].

The Ebola epidemic has initiated global preparedness and response. Since nobody can predict where a patient with Ebola might go, each hospital and health care facility must be ready to and must evaluate the risk and procedures to isolate a patient with Ebola. Key points of preparedness are facility leadership, written and rehearsed standardized operating procedures, staff training and oversight of practices of PPE [9].

The current Ebola outbreak is entering its second year and it seems that will continue during 2015. At the end of this outbreak affected countries and international community should require evaluation of interventions and address economic and social impacts as well as plan for the rebuilding of health care systems [10].

Acknowledgements

Author has been part of Ebola response team in Liberia during 2014 as consultant of World Health Organization.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11684
  • [From(publication date):
    March-2015 - Oct 20, 2017]
  • Breakdown by view type
  • HTML page views : 7897
  • PDF downloads :3787
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords